D-1088-2017 Class III Terminated
FDA drug recall D-1088-2017 was initiated by Akorn Inc on Jul 12, 2017 and is designated Class III. Reason for recall: Crystallization with subpotent out of specification assay results for chlorhexidine. The recall status is terminated (terminated Jun 19, 2018). Affected quantity: 541,900 unit dose cups (5,419 trays).
Recall details
- Product Type
- Drugs
- Report Date
- Aug 23, 2017
- Initiation Date
- Jul 12, 2017
- Termination Date
- Jun 19, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 541,900 unit dose cups (5,419 trays)
Product description
Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL Unit Dose Cup, a) unit dose cup (NDC 50383-720-15), b) 100-count tray (NDC 50383-720-19), Rx Only, Hi-Tech Pharmacal Co. Inc., Amityville, NY 11701.
Reason for recall
Crystallization with subpotent out of specification assay results for chlorhexidine.
Distribution pattern
Nationwide in the USA
Code information
Lot: 353394, Exp 10-2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1088-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026